Drug Development

Reducing the <i>P</i>-Value for Statistical Significance to Improve the Quality of Research?

Reducing the P-Value for Statistical Significance to Improve the Quality of Research?

By

In a controversial and divisive article, a group of researchers proposes to improve "statistical standards of evidence" by lowering the P value from P <.05 to P <.005 in the fields of biomedical and social sciences.

New Pain Management Drugs to Know About

New Pain Management Drugs to Know About

By

Multiple new drugs for pain management have been recently introduced or approved, and additional agents are currently under investigation.

Interchangeability Study Initiated for Adalimumab Biosimilar

Interchangeability Study Initiated for Adalimumab Biosimilar

By

Boehringer Ingelheim has initiated a clinical study to investigate the interchangeability between an adalimumab biosimilar candidate and Humira.

Aimovig Under Review for Migraine Prophylaxis

Aimovig Under Review for Migraine Prophylaxis

By

The FDA has accepted for review the Biologics License Application for Aimovig for migraine prophylaxis in patients experiencing more than 4 migraine days per month.

Three Upcoming Pain Drugs

Three Upcoming Pain Drugs

By

Pharmaceutical companies are working to develop non-opioid drugs for chronic and postoperative pain.

What the FDA Can Do to Help Bring Improved Pain Medicines to the Market

What the FDA Can Do to Help Bring Improved Pain Medicines to the Market

By

Dr Katz formulated 10 recommendations for the FDA, 3 of which he detailed during his presentation.

The Issues With Clinical Studies That Impede the Development of New Pain Drugs

The Issues With Clinical Studies That Impede the Development of New Pain Drugs

By

Drug development faces 2 major issues: pre-clinical animal efficacy studies do not accurately predict human efficacy, and clinical trials often wrongly fail to show drug efficacy.

Big Data to Address Chronic Pain

Big Data to Address Chronic Pain

🎥 Dr James Campbell's team is developing safe, non-addictive and effective therapies to treat chronic pain using a big data approach, and focusing on osteoarthritis, chronic low back pain and headache.

Sign Up for Free e-Newsletters